Correspondence 0001564590-23-001665 from MAIA Biotechnology, Inc. (MAIA) (CIK 0001878313) (MAIA)
MAIA Biotechnology, Inc. (MAIA) (CIK 0001878313)
Date: Feb. 9, 2023 · CIK: 0001878313 · Accession: 0001564590-23-001665
AI Filing Summary & Sentiment
File numbers found in text: 333-269606
Letter
maia-corresp.htm
ThinkEquity LLC
17 State Street, 41st Floor
New York, NY 10004
February 9, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
Washington, D.C. 20549
Attention: Jimmy McNamara
RE:
MAIA Biotechnology, Inc.
Registration Statement on Form S-1
Filed February 6, 2023
File No. 333-269606
Ladies and Gentlemen:
As the underwriter of the proposed offering of MAIA Biotechnology, Inc. (the “Company”), we hereby withdraw our prior letter to join the acceleration request of the Company dated February 7, 2023 for the above-referenced Registration Statement.
Very truly yours,
THINKEQUITY LLC
Show Raw Text
CORRESP 1 filename1.htm maia-corresp.htm ThinkEquity LLC 17 State Street, 41st Floor New York, NY 10004 February 9, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Washington, D.C. 20549 Attention: Jimmy McNamara RE: MAIA Biotechnology, Inc. Registration Statement on Form S-1 Filed February 6, 2023 File No. 333-269606 Ladies and Gentlemen: As the underwriter of the proposed offering of MAIA Biotechnology, Inc. (the “Company”), we hereby withdraw our prior letter to join the acceleration request of the Company dated February 7, 2023 for the above-referenced Registration Statement. Very truly yours, THINKEQUITY LLC By: /s/ Eric Lord Name: Eric Lord Title: Head of Investment Banking